PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 6, 2026Pathogens1 citationsOpen Access

RISK6 As A Biomarker for Tuberculosis Diagnosis, Monitoring, and Risk Assessment

RISK6  as a Translational Host Transcriptomic Signature for Tuberculosis Diagnosis, Treatment Monitoring, and Risk Stratification 

View Full Paper

Authors

CMChrispian MamudiPPurnamawatiPAPanca Andana

Discussion

Loading...

Member takes

Overview

Review summarizes RISK6's role as a diagnostic tool for tuberculosis, indicating its clinical significance.

Key Points

  • This review evaluates the RISK6 transcriptomic signature as a potential biomarker for diagnosing and monitoring tuberculosis and stratifying patient risk.
  • Clinically oriented synthesis of existing evidence on the RISK6 signature.
  • Assessment of diagnostic performance and applicability across tuberculosis disease spectrum.
  • Examination of limitations in multidrug-resistant tuberculosis populations.
  • RISK6 shows promising diagnostic performance with context-dependent variability.
  • It functions better within integrated frameworks including clinical data.
  • Limited evidence highlights its challenges as a standalone biomarker.
Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Mamudi et al. (2026) studied this question.

synapsesocial.com/papers/69fadaab03f892aec9b1e608https://doi.org/10.3390/pathogens15050489
Ask AI
Helpful
Bookmark
Share
View Full Paper